Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

709

Figures (1-3)

Tables (1-3)

Sum=826

Publishing Process of This Article

Item

Count

Browse

Download

120

Sum=166

Mar 27, 2024 (publication date) through May 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Hepatol. Mar 27, 2024; 16(3): 393-404
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.393

Full Size Figure Download Figure

Figure 1 Study cohort by body mass index class. BMI: Body mass index class.

Citation: deLemos AS, Zhao J, Patel M, Kooken B, Mathur K, Nguyen HM, Mazhar A, McCarter M, Burney H, Kettler C, Chalasani N, Gawrieh S. Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma. World J Hepatol 2024; 16(3): 393-404
URL: https://www.wjgnet.com/1948-5182/full/v16/i3/393.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i3.393